Navigation Links
BioScrip To Present At "NINE" Noble Financial Capital Markets' Ninth Annual Equity Conference
Date:1/17/2013

ELMSFORD, N.Y., Jan. 17, 2013 /PRNewswire/ -- BioScrip (NASDAQ: BIOS) today announced that the Company will present at "NINE" Noble Financial Capital Markets' Ninth Annual Equity Conference to be held January 21-23, 2013 at the Hard Rock Hotel in Hollywood, Florida.

(Logo: http://photos.prnewswire.com/prnh/20130117/NY44138LOGO )

Hai Tran , Chief Financial Officer, will present on Tuesday, January 22, 2013 at 10:30 am Eastern Standard Time. 

About BioScrip, Inc.
BioScrip, Inc. provides comprehensive infusion and home care solutions. By partnering with patients, physicians, healthcare payors, government agencies and pharmaceutical manufacturers we are able to provide access to infusible medications and management solutions. Our goal is to optimize outcomes for chronic and other complex healthcare conditions and enhance the quality of patient life. BioScrip brings clinical competence in providing high-touch, comprehensive infusion and nursing services to patients in the most convenient ways possible. Through our customer services and treatments we aim to ensure the best possible therapy outcome.


'/>"/>
SOURCE BioScrip, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. OncoSec Medical to Present at Noble Financial Capital Markets Ninth Annual Equity Conference on January 22
2. Ansell y Comasec presentan Shared World of Innovation en ExpoProtection 2012
3. MiMedx Group to Present at the 6th Annual OneMedForum
4. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, in Relapsed/Refractory Mantle Cell Lymphoma Presented at American Society of Hematology Annual Meeting
5. Ambit and Astellas Announce Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the 54th Annual Meeting of the American Society of Hematology
6. Hospira to Present at the J.P. Morgan 31st Annual Healthcare Conference Jan. 8, 2013
7. Thoratec Presentation At Oppenheimer 23rd Annual Healthcare Conference To Be Webcast
8. Boehringer Ingelheim Presents New Phase II Data for Volasertib in Adult Patients with AML
9. Henry Schein To Present At The Oppenheimer 23rd Annual Healthcare Conference
10. Aratana to Present at Bank of America Merrill Lynch Animal Health Summit
11. PROLOR Biotech To Present Preclinical Data On Its Long-Acting Clotting Factor Vlla At 2012 ASH Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... , April 29, 2016 ... glyco-biology expertise, today announces the appointment of Dr. ... Dr. Zurlo is an oncologist with many years clinical ... and biotechnology industries. His last role was at Mologen ... of the Executive Board. Previously Dr. Zurlo held various ...
(Date:4/28/2016)... Calif. , April 28, 2016  Marking ... widely accessible breast and ovarian cancer risk test, ... panel analyzing 30 genes that highly impact the ... women. Available today, the Color Test analyzes hereditary ... prostate, stomach, and uterine cancers. The Color Test ...
(Date:4/28/2016)... 2016 Dr. Vivek Ahuja , ... Ste phen Schmidt ... provider of cloud-based software solutions for life sciences, today announced key ... a wealth of insight to a growing business.  This will bolster ... George Phillips joined ArisGlobal in the position of Vice ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... 29, 2016 , ... Conditions were ideal for Global Lyme Alliance’s (GLA) 2nd ... sunny skies, a light breeze and temperatures in the 60s. Over 400 runners, walkers ... and Walk and 1-mile walk were held to increase awareness about Lyme disease ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... infants born with severe congenital diaphragmatic hernia have better survival rates if surgery ... diaphragmatic hernia (CDH)—a condition where the diaphragm fails to form completely, letting abdominal ...
(Date:4/29/2016)... ... 2016 , ... The Wharton School of the University ... of the 2016 Wharton Business Plan Competition —as well as the Wharton ... the Committee Award for Most ‘Wow Factor,’ making them the first team in ...
(Date:4/29/2016)... ... 29, 2016 , ... World Patent Marketing , a ... invention which aids in proper muscle development. , "The Gym & Exercise Equipment ... of World Patent Marketing. "Globalization has threatened the future growth of the industry ...
(Date:4/29/2016)... ... ... deadliest type of skin cancer. Although only about 1 percent of skin cancer cases are ... people are expected to die of melanoma this year. The risk increases with age, and ... commonly diagnosed cancers in young women. A recent breakthrough in genetic studies may give doctors ...
Breaking Medicine News(10 mins):